Joel Elkes

Joel Elkes
Born(1913-11-12)November 12, 1913
DiedOctober 30, 2015(2015-10-30) (aged 101)
Alma mater
Scientific career
Institutions

Joel Elkes (12 November 1913 – 30 October 2015) was a leading medical researcher specialising in the chemistry of the brain. He qualified as a physician in London and later became a medical researcher who published the first double-blind scientific trial on chlorpromazine to treat schizophrenia.[1] He is regarded as the father of modern neuropsychopharmacology and directed the first experimental psychiatric Uffculme Clinic in Birmingham, UK. He was responsible for the setting up of international organisations and university departments to further the investigation of the effects of psychopharmacy. He spent the latter part of his career endeavouring to bring higher levels of humanity, compassion and ethics to medical training.[2]

  1. ^ "Joel Elkes, Who Cast Light on Brain Chemistry and Behavior, Dies at 101". The New York Times. Nov 17, 2015. Retrieved November 18, 2015.
  2. ^ Blackwell, Barry (20 August 2015), Joel Elkes, An Integrative Life (PDF), retrieved 29 Dec 2015